Crossref
SGLT2 inhibitors and contrast-associated acute kidney injury
Kardiologia Polska · 2024
DOI: 10.33963/v.kp.98717 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kardiologia Polska, 2024. Verfasst von Richard Solomon. Beteiligte Einrichtung: University of Vermont Larner College of Medicine, Burlington, Vermont, United States. richard.solomon@uvmhealth.org. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Acute Kidney Injury, Diabetes Mellitus, Type 2.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Sodium-Glucose Transporter 2 InhibitorsAcute Kidney InjuryDiabetes Mellitus, Type 2HumansHypoglycemic AgentsKidney
Substanzen
Sodium-Glucose Transporter 2 InhibitorsHypoglycemic Agents
Autor:innen und Institutionen
- University of Vermont Larner College of Medicine, Burlington, Vermont, United States. richard.solomon@uvmhealth.org.
Zitieren
APA
Solomon, R. (2024). SGLT2 inhibitors and contrast-associated acute kidney injury. Kardiologia Polska. https://doi.org/10.33963/v.kp.98717
Vancouver
Solomon R. SGLT2 inhibitors and contrast-associated acute kidney injury. Kardiologia Polska. 2024. doi:10.33963/v.kp.98717
BibTeX
@article{Solomon2024,
author = {Solomon, Richard},
title = {SGLT2 inhibitors and contrast-associated acute kidney injury},
journal = {Kardiologia Polska},
year = {2024},
doi = {10.33963/v.kp.98717}
}
EUVIMED